Enhanced Immunological Tolerance against Allograft Rejection by Oral Administration of Allogeneic Antigen Linked to Cholera Toxin B Subunit

This publication has 18 references indexed in Scilit:

• Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine
  Arthritis & Rheumatism, 1999
• A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes
  Proceedings of the National Academy of Sciences, 1997
• Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.
  Proceedings of the National Academy of Sciences, 1996
• Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.
  Proceedings of the National Academy of Sciences, 1994
• Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens
  Annual Review of Immunology, 1994
• ORAL, BUT NOT INTRAVENOUS, ALLOANTIGEN PREVENTS ACCELERATED ALLOGRAFT REJECTION BY SELECTIVE INTRAGRAFT TH2 CELL ACTIVATION
  Transplantation, 1993
• Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.
  Proceedings of the National Academy of Sciences, 1992
• DOWN-REGULATION OF THE IMMUNE RESPONSE TO HISTOCOMPATIBILITY ANTIGENS AND PREVENTION OF SENSITIZATION BY SKIN ALLOGRAFTS BY ORALLY ADMINISTERED ALLOANTIGEN1
  Transplantation, 1992
• BREAST FEEDING AND MATERNAL-DONOR RENAL ALLOGRAFTS
  Transplantation, 1984
• Immunologic Benefits and Hazards of Milk in Maternal-Perinatal Relationship
  Annals of Internal Medicine, 1975